Triple Pill For High Blood Pressure
The FDA has approved a new pill called Widaplik, which combines three drugs telmisartan, amlodipine, and indapamide to treat adults who have high blood pressure. The medication, sold under the brand name Widaplik, is the first single pill to merge three approved drugstelmisartan, amlodipine, and indapamide. This triple-action approach can help people who normally take several pills to control their blood pressure.
The FDA has approved Widaplik, a once-daily triple combination pill, to treat high blood pressure in adults. A new option to treat high blood pressure is coming soon and it could make a big difference for the millions of people who need more than one medication to manage their condition. A novel single-pill combination of telmisartan, amlodipine, and indapamide (GMRx2, Widaplik; George Medicines) has been approved by the FDA for the treatment of adult patients with hypertension, including as an initial treatment and to lower blood pressure.
The single pill (Widaplik), which contains the ARB telmisartan, calcium-channel blocker amlodipine, and diuretic indapamide, is the first triple combination medication approved by the FDA as an initial treatment for patients likely to need multiple medications to lower blood pressure. A Triple-Action Pill in One Dose WIDAPLIK is the first and only FDA-approved triple combination antihypertensive therapy available for patients at the start of their treatment journey.
